Method development and validation of taraxerol by using high performance liquid chromatography
Taraxerol is a bioactive compound found in several higher plants that exhibits many specific biological effects, particularly in the field of medicine. Although taraxerol has limited antioxidative efficacy and only modest antibacterial activities, many studies have shown its promise as an anti-plasmodial, antidiabetic, anticancer, anti-inflammatory, and anti-dermatophyte agent. A robust analytical approach for quantifying Taraxerol using High Performance Liquid Chromatography (HPLC) is the main objective of this research endeavor. An analysis of Taraxerol revealed a retention time of 3.519 minutes. Within the concentration range of 20-70 μg/mL, the drug exhibited a linear relationship, with a correlation coefficient of 0.999. The determination of the limit of detection (LOD) and limit of quantitation (LOQ) yielded values of 0.0026 μg/mL and 0.0081 μg/mL each. The accuracy of the approach was considered satisfactory, as the average recovery percentage was within the allowed range of 99.92-100.33%.
Institutions
- Dr. D. Y. Patil Medical College, Hospital and Research Centre (IN)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2024-09-30
- DOI
- https://doi.org/10.5281/zenodo.14709410
- Primary Topic
- Tissue Engineering and Regenerative Medicine
- Type
- article
- Field-Weighted Citation Impact
- 0.00